Safety, Tolerability, and Immunogenicity of Revaccination with mRNA-1345, an Investigational Vaccine Against RSV, Given at 12 Months Following a Primary Dose in Adults Aged ≥50 Years
Exploring the Prevalence of Human Papillomavirus (HPV) Genotypes in PAP Smear Samples of Women in Northern Region of United Arab Emirates: Peptide Nucleic Acid-Based Fluorescence Melting Curve Analysis Study
Patient Safety Initiative to Reduce Central Line–Associated Bloodstream Infections Among Adults Intensive Care Units Patients in Tertiary Care Hospital in Saudi Arabia: A “Zero Harm” Approach